Retinoblastoma — Trials

Retinoblastoma — Trials · CancerIndex

Clinical trials

Registered studies

110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 8
Ph III recruiting: 3
Growth YoY: —
Industry share: 7%
Top sponsor: Institut Curie
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04156347	Topotecan Episcleral Plaque for Treatment of Retinoblastoma	unknown	Phase 1	42	Targeted Therapy Technologies, LLCINDUSTRY	1	Oct 31, 2023	clinicaltrials
NCT00906113	Intra-arterial Chemotherapy for Children With Retinoblastoma	unknown	Phase 1 / Phase 2	10	Hadassah Medical OrganizationOTHER	1	Oct 4, 2016	clinicaltrials